Get your daily news on healthcare and wellness

Provided by AGP

World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on April 18, 2026

BrainFunHub Launches Free, Fun Brain Games for Seniors, Families, and Caregivers
Precision Health Chiropractic to Host Community Health Fair Focused on Natural, Non-Invasive Wellness
Toni Higginbotham Lifestyle Magazine Confirm Running Features On Specialist Sydney Building Companies To Start In May.
Cearvol Wave Receives 'Expert Choice 2026' Recognition from HearAdvisor
Toni Higginbotham Media Commence Informative Features On Organising Winter Weddings & Events In Melbourne
SleepLean Claims Evaluated: The Fat Burning Sleep Lean Ingredients Under Investigation for Weight Loss Benefits
Herz P1 Smart Oximeter Claims Evaluated: Best Pulse Oxygen Monitor Device on the Market with Clinical-Grade Accuracy
Quietum Plus Claims Evaluated: The Time-Tested Ear Ringing Relief Formula for Tinnitus Support Under Investigation
MemoShield Claims Evaluated: Empower Health Labs Memory Support Formula for Brain Boosting Health Benefits
Vigor Boost Gummies Claims Evaluated: The ForceVital Male Enhancement Formula Under Investigation
Hewelth ReliefChain Claims Evaluated: Deep Muscle Pulse Therapy Massager for Neck & Shoulders Relief
SlimLeaf Claims Evaluated: The FitBurn Formula Using Slim Leaf Ingredients for Weight Loss
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095  in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026
MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe  
VigoSurge Claims Evaluated: Analyzing the Ingredients' Benefits, Side Effects Risk and Customer Complaints
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
2026 Fujian Provincial Conference on Development of Cultural, Tourism Economy opens on Apr. 17 in Zhangzhou, SE China's Fujian

Share us

on your social networks:

Sign up for:

World Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.